Creative Medical Technology Holdings (OTC:CELZ) touted its exosome technology today, reporting that it demonstrated an ability to regenerate healthy brain cells while selectively halting the growth of glioma brain cancer cells in a preclinical model.
The company’s exosomes are vesicles harvested from amniotic stem cell technology, which it licensed from the University of California San Diego in an exclusive deal for the AmnioStem platform.
Get the full story at our sister site, Drug Delivery Business News.
The post Nanotech derived from amniotic stem cells could help treat brain cancer appeared first on MassDevice.
from MassDevice http://ift.tt/2tYJJOX
Cap comentari:
Publica un comentari a l'entrada